Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Squamous Cell × Therapeutics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Prostatic Neoplasms 4 Multiple Myeloma 4 Lymphoma, T-Cell, Cutaneous 4 Lymphoma, Non-Hodgkin 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Myeloid, Acute 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Burkitt Lymphoma 4 Waldenstrom Macroglobulinemia 3 Sezary Syndrome 3 Recurrence 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 3 Mycosis Fungoides 3 Lymphoma, Extranodal NK-T-Cell 3 Leukemia, Hairy Cell 3 Hodgkin Disease 3 Breast Neoplasms 3 Brain Neoplasms 3 Blast Crisis 3 Melanoma 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2

Interventions

Cisplatin 39 Carboplatin 21 Radiotherapy 20 Cetuximab 19 Paclitaxel 18 Docetaxel 16 Radiotherapy, Intensity-Modulated 15 pembrolizumab 14 Fluorouracil 13 Drug Therapy 10 Radiation 6 Nivolumab 6 cemiplimab 5 atezolizumab 5 Panitumumab 5 Erlotinib Hydrochloride 5 Oxaliplatin 4 Chemoradiotherapy 4 Afatinib 4 durvalumab 3 Surveys and Questionnaires 3 Surgical Procedures, Operative 3 Leucovorin 3 Lapatinib 3 130-nm albumin-bound paclitaxel 3 toripalimab 2 palbociclib 2 dacomitinib 2 cabozantinib 2 avelumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05038657 2022-10-03

AURORA

University Hospital Southampton NHS Foundation Trust

Phase 2 Unknown

Carcinoma, Squamous Cell, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡